Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review

Malignant peritoneal mesothelioma (MPM) is a rare and invasive tumor, and some patients will develop paraneoplastic syndrome (PS) during the course of the disease. This review summarizes PS associated with MPM, focusing on the clinical characteristics and treatment progress in hematological, endocri...

Full description

Saved in:
Bibliographic Details
Published inJournal of surgical oncology Vol. 130; no. 3; pp. 533 - 542
Main Authors Liang, Xin‐Li, Li, Xin‐Bao, Fu, Yu‐Bin, Su, Yan‐Dong, Ma, Ru, Yang, Rui, Wu, He‐Liang, Li, Yan
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2024
Subjects
hypoglycemia
malignant peritoneal mesothelioma
neoplastic fever
nephrotic syndrome
paraneoplastic syndrome
thrombocytosis
thrombocytosis
malignant peritoneal mesothelioma
neoplastic fever
nephrotic syndrome
hypoglycemia
paraneoplastic syndrome
Online AccessGet full text

Cover

More Information
Summary:Malignant peritoneal mesothelioma (MPM) is a rare and invasive tumor, and some patients will develop paraneoplastic syndrome (PS) during the course of the disease. This review summarizes PS associated with MPM, focusing on the clinical characteristics and treatment progress in hematological, endocrine, rheumatic, neurological, urinary, and other systems to decrease missed diagnosis and misdiagnosis, help early diagnosis and prompt treatment, and provide guidance for the clinical decision‐making of this kind of patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0022-4790
1096-9098
1096-9098
DOI:10.1002/jso.27737